• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of the Canadian Academy of Child and Adolescent Psychiatry >Efficacy of Methylphenidate in ADHD Children across the Normal and the Gifted Intellectual Spectrum
【24h】

Efficacy of Methylphenidate in ADHD Children across the Normal and the Gifted Intellectual Spectrum

机译：正常和有天赋的智力谱图中哌醋甲酯对多动症儿童的疗效

获取原文
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: This study evaluates whether attention-deficit/hyperactivity disorder (ADHD) children with a borderline intelligence quotient (IQ) (70≤FSIQ<80), normal IQ (80≤FSIQ<120) and high IQ (FSIQ≥120) respond differently to psychostimulant treatment. Method: 502 children, aged 6 to 12 years, with an IQ range from 70 to 150 participated in a two-week, double-blind, placebo-controlled, crossover methylphenidate (MPH) trial. Results: In addition to differences in socioeconomic background and parental education, higher IQ children were found to present with less severe symptoms. No significant differences were found with regards to treatment response. Conclusion: ADHD children within the normal and high levels of intellectual functioning all respond equally to psychostimulant treatment, and that proper medication management is necessary for all children with the disorder.
机译：目的：本研究评估具有临界智力商（IQ）（70≤FSIQ<80），智商正常（80≤FSIQ<120）和高智商（FSIQ≥120）的注意缺陷/多动障碍（ADHD）儿童是否有反应与心理刺激治疗不同。方法：502名智商在70至150之间，年龄在6至12岁之间的儿童参加了为期两周的双盲，安慰剂对照，交叉哌醋甲酯（MPH）试验。结果：除了社会经济背景和父母受教育程度不同外，智商较高的儿童还表现出较轻的症状。在治疗反应方面未发现显着差异。结论：正常和智力水平高的多动症儿童对精神刺激治疗的反应均相同，并且对所有患有这种疾病的儿童都需要适当的药物管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号